USFDA completes PAI, GMP inspection at Dr. Reddy's Laboratories’ Andhra Pradesh facility

20 Jul 2023 Evaluate

United States Food & Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) and a routine GMP inspection at Dr. Reddy's Laboratories’ API manufacturing facility in Srikakulam, Andhra Pradesh, India (CTO-6). The inspection was conducted from July 10, 2023 to July 19, 2023. The inspection closed with zero observations and a classification of No Action Indicated (NAI). 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5812.50 13.25 (0.23%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.